Table 4.
Comparison of hematological and electrolyte parameters based on clinical stages.
| Parameter (Mean ± SD) |
Stage I and II (lower stage) | Stage III and IV (advanced stage) | ||||
|---|---|---|---|---|---|---|
| Untreated (n=57) |
Treated (n=56) |
p-value | Untreated (n=43) |
Treated (n=44) |
p-value | |
| TWBC (/µL) | 8.87±1.73 | 5.64±1.43 | 0.000 | 7.94±1.89 | 4.77±1.52 | <0.0001 |
| NE (/µL) | 4.41±1.48 | 2.27±.82 | 0.000 | 3.75±1.42 | 1.93±.76 | <0.0001 |
| LY(/µL) | 2.74±1.42 | 1.83±.94 | 0.000 | 2.74±1.22 | 1.31±.71 | <0.0001 |
| MO(/µL) | 0.83±.37 | 0.89±.36 | 0.415 | 0.81±.38 | 0.82±.30 | 0.929 |
| EO(/µL) | 0.63±.44 | 0.76±.48 | 0.150 | 0.50±.33 | 0.73±.43 | 0.007 |
| BA(/µL) | 0.14±.10 | 0.13±.17 | 0.965 | 0.13±.15 | 0.15±.13 | 0.559 |
| RBC(/µL) | 4.54±.54 | 4.29±.58 | 0.020 | 4.49±.51 | 3.77±.60 | <0.0001 |
| Hgb (g/dL) | 12.66±1.43 | 11.49±.71 | 0.000 | 12.27±1.05 | 10.56±.71 | <0.0001 |
| HCT (%) | 37.76±4.34 | 34.16±1.92 | 0.000 | 35.98±3.23 | 31.56±1.93 | <0.0001 |
| RDW (%) | 12.96±2.06 | 17.75±2.44 | 0.000 | 12.71±1.36 | 19.21±2.97 | <0.0001 |
| MCV (fL) | 82.94±7.57 | 80.70±9.35 | 0.164 | 80.66±8.13 | 79.41±6.91 | 0.440 |
| MCH (pg) | 28.22±2.59 | 27.13±3.26 | 0.051 | 27.49±2.7 | 28.44±3.30 | 0.148 |
| MCHC(g/dL) | 33.67±.93 | 33.63±1.06 | 0.830 | 33.54±1.35 | 33.43±1.25 | 0.687 |
| PLT(/µL) | 272.0±81.9 | 313.1±119.7 | 0.036 | 210.77±50.4 | 451.2±145.5 | <0.0001 |
| MPV (%) | 8.28±1.11 | 8.20±.99 | 0.676 | 8.16±1.18 | 7.65±1.26 | 0.054 |
| PCT (%) | 0.14±.04 | 0.19±.08 | 0.000 | 0.13±.03 | 0.26±.08 | <0.0001 |
| Na+(mmol/L) | 142.9±4.58 | 133.92±4.48 | 0.000 | 141.76±4.29 | 132.59±7.71 | <0.0001 |
| K+ (mmol/L) | 3.76±.52 | 4.95±.94 | 0.000 | 3.87±.48 | 5.57±1.13 | <0.0001 |
| Ca+2 (mg/dL) | 8.82±1.03 | 8.93±.78 | 0.545 | 8.35±.55 | 8.52±1.22 | 0.385 |
TWBC, Total White Blood Cell; NE, Neutrophil; LY, Lymphocyte; MO, Monocyte; EO, Eosinophils; BA, Basophil; RBC, Red Blood Cell; Hgb, Hemoglobin; HCT, Hematocrit; RDW, Red Cell Distribution Width; MCV, Mean Cell Volume; MCH, Mean Cell Hemoglobin; MCHC, Mean Cell Hemoglobin Concentration; PLT, Platelet; MPV, Mean Platelet Volume; PCT, Plateletcrit; Na+, Sodium; Ca2+, Calcium; K+, Potassium; AC, Adriamycin-Cytoxan. Continuous variables were expressed as mean ± standard deviation (SD) and p-value < 0.05 implies a significant difference between the two study group’s variables.